^Heinz S, Krause SW, Gabrielli F, Wagner HM, Andreesen R, Rehli M (Apr 2002). "Genomic organization of the human gene HEP27: alternative promoter usage in HepG2 cells and monocyte-derived dendritic cells". Genomics. 79 (4): 608–15. doi:10.1006/geno.2002.6743. PMID11944995.
^Shafqat N, Shafqat J, Eissner G, Marschall HU, Tryggvason K, Eriksson U, Gabrielli F, Lardy H, Jornvall H, Oppermann U (Jun 2006). "Hep27, a member of the short-chain dehydrogenase/reductase family, is an NADPH-dependent dicarbonyl reductase expressed in vascular endothelial tissue". Cell Mol Life Sci. 63 (10): 1205–13. doi:10.1007/s00018-006-6013-y. PMID16685466. S2CID24562253.
Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID8125298.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Pellegrini S, Censini S, Guidotti S, et al. (2002). "A human short-chain dehydrogenase/reductase gene: structure, chromosomal localization, tissue expression and subcellular localization of its product". Biochim. Biophys. Acta. 1574 (3): 215–22. doi:10.1016/s0167-4781(01)00323-2. PMID11997086.